Skip to content

INTELLIGENT BIO SOLUTIONS INC.: 10-Q filed 2022-05-16

What INTELLIGENT BIO SOLUTIONS INC. reported in its quarterly report filed 2022-05-16 (fiscal Q3 2022): 28 published measures, 80 facts as tagged in accession 0001493152-22-013610.

This filing

Form
10-Q (quarterly report)
Filed
2022-05-16
Fiscal period
fiscal Q3 2022
Accession
0001493152-22-013610 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTELLIGENT BIO SOLUTIONS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-03-3114,359,053USD
At 2021-06-3021,859,369USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-03-315,655,562USD
At 2021-06-306,852,748USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-03-318,772,617USD
At 2021-06-3015,057,847USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-03-3110,756,089USD
At 2021-06-3012,573,685USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-03-31-1,335,246USD90
2021-07-01 to 2022-03-31-6,227,896USD274
2021-01-01 to 2021-03-31-3,127,813USD90
2020-07-01 to 2021-03-31-6,184,287USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-07-01 to 2022-03-31-1,634,829USD274
2020-07-01 to 2021-03-31-9,613,666USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-01-01 to 2022-03-31192,500USD90
2021-07-01 to 2022-03-31370,291USD274
2021-01-01 to 2021-03-3134,290USD90
2020-07-01 to 2021-03-31372,754USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-07-01 to 2021-03-3123,402,918USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-07-01 to 2022-03-31-177,208USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-03-31-29,097,699USD
At 2021-06-30-22,869,803USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-01-01 to 2022-03-3114,889,904shares90
2021-07-01 to 2022-03-3114,590,656shares274
2021-01-01 to 2021-03-3111,795,741shares90
2020-07-01 to 2021-03-319,667,399shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-01-01 to 2022-03-31-0.09USD/shares90
2021-07-01 to 2022-03-31-0.43USD/shares274
2021-01-01 to 2021-03-31-0.27USD/shares90
2020-07-01 to 2021-03-31-0.64USD/shares274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-03-31-1,342,829USD90
2021-07-01 to 2022-03-31-6,248,783USD274
2021-01-01 to 2021-03-31-3,140,515USD90
2020-07-01 to 2021-03-31-4,720,836USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-03-3112,865,423USD
At 2021-06-3018,207,041USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-03-314,432,175USD
At 2021-06-303,682,650USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-01-01 to 2022-03-311,535,329USD90
2021-07-01 to 2022-03-316,619,074USD274
2021-01-01 to 2021-03-313,174,805USD90
2020-07-01 to 2021-03-315,093,590USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-03-3114,889,904shares
At 2021-06-3013,582,122shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-03-3138,440,011USD
At 2021-06-3038,440,089USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-03-31-718,594USD
At 2021-06-30-661,260USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2022-03-318,703,491USD
At 2021-12-3110,044,831USD
At 2021-09-3013,501,299USD
At 2021-06-3015,006,621USD
At 2021-03-3115,875,416USD
At 2020-12-3118,782,015USD
At 2020-09-30-3,047,566USD
At 2020-06-30-5,214,828USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-06-30504,000USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-01-01 to 2022-03-31-1,344,133USD90
2021-07-01 to 2022-03-31-6,245,796USD274
2021-10-01 to 2021-12-31-3,463,823USD92
2021-07-01 to 2021-09-30-1,437,840USD92
2021-01-01 to 2021-03-31-3,142,667USD90
2020-07-01 to 2021-03-31-6,209,971USD274
2020-10-01 to 2020-12-31-1,990,389USD92
2020-07-01 to 2020-09-30-1,076,915USD92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-01-01 to 2022-03-31-1,332,453USD90
2021-07-01 to 2022-03-31-6,285,230USD274
2021-01-01 to 2021-03-31-3,389,845USD90
2020-07-01 to 2021-03-31-6,463,031USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-03-311,122,004USD90
2021-07-01 to 2022-03-313,457,768USD274
2021-01-01 to 2021-03-311,013,389USD90
2020-07-01 to 2021-03-312,205,842USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-01-01 to 2022-03-31-1,304USD90
2021-07-01 to 2022-03-312,987USD274
2021-01-01 to 2021-03-31-2,152USD90
2020-07-01 to 2021-03-31-1,489,135USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-07-01 to 2021-03-31185,301USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-07-01 to 2021-03-31508,300USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-07-01 to 2022-03-31-1,828,891USD274

Inspect the source

Entity
INTELLIGENT BIO SOLUTIONS INC. / CIK 0001725430
Captured
2026-09-21T17:27:32.532Z
SEC response SHA-256
853a52aa5d475439c28611414a5b3e3bab760df6971e6f435df2e4acd29b2f46

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001725430.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))